Evidence map›Paper›PMID 42883148›Full record

ArticleMolecules (Basel, Switzerland)2026

Can Molecular Docking Predict Guest Orientation in β-Cyclodextrin? A Cross-Docking and DFT Refinement Study.

Ewa Napiórkowska, Konrad Adam Michalik, Łukasz Szeleszczuk

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ewa NapiórkowskaDepartment of Organic and Physical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Str., 02-093 Warsaw, Poland.ORCID 0009-0008-3417-518X
Konrad Adam MichalikDepartment of Organic and Physical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Str., 02-093 Warsaw, Poland.ORCID 0009-0004-4485-8903
Łukasz SzeleszczukDepartment of Organic and Physical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Str., 02-093 Warsaw, Poland.ORCID 0000-0002-5302-3797

Funding

Medical University of Warsaw 16/F/MG/N/25
6 · The paper itself

Abstract

Molecular docking is widely used to predict cyclodextrin host-guest structures, yet its ability to reproduce the directional orientation of asymmetric guests within the β-cyclodextrin (β-CD) cavity has rarely been evaluated systematically. Here, 20 crystallographically characterized 1:1 β-CD complexes containing asymmetric 1,4-disubstituted benzene guests were selected from the Cambridge Structural Database. Each guest was docked into each of 20 experimentally derived β-CD conformations, yielding 7916 retained poses. Poses reproducing the crystallographic direction of inclusion were classified as Up, whereas the opposite orientation was classified as Down. Across the complete dataset, approximately 26% of poses were Up, with guest-dependent frequencies ranging from 5% to 83%. Importantly, only one β-CD conformation generated Up poses for all 20 guests, whereas the complete receptor set sampled at least one crystal-consistent pose for every compound. However, GlideScore-based orientation recovery was 65% for Top-1, 95% for Top-2, and 100% for Top-3, demonstrating that successful sampling does not necessarily ensure correct top-ranked prediction. Selected poses were subsequently optimized using dispersion-corrected DFT. DFT-based energetic ranking did not consistently favour the crystallographic orientation and could either decrease or increase guest heavy-atom RMSD. Overall, the results demonstrate that reliable validation of β-CD docking requires explicit separation of pose generation, pose ranking, energetic refinement, and structural similarity, and support the use of structurally diverse crystal-derived receptor sets to broaden orientational sampling.

Indexed as

DFTguest propertiesinclusion complexesmolecular dockingβ-cyclodextrins

Identifiers

PMID42883148
PMCPMC13665827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.